跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 54,042 条关于
“chronic immune thrombocytopenia”
全部
54,042
临床试验
40,962
药物
708
机构
139
资讯
12,233
去年
CASI Pharmaceuticals Initiates Phase 1/2 Trial of CID-103 for Immune Thrombocytopenia
去年
FDA Approves Doptelet for Pediatric Immune Thrombocytopenia with New Sprinkle Formulation
去年
Sanofi's Wayrilz Becomes First BTK Inhibitor Approved for Immune Thrombocytopenia Treatment
去年
Handok Gains Korean Approval for Doptelet to Treat ITP and CLD-Related Thrombocytopenia
去年
Rilzabrutinib Shows Promise in Phase 3 Trial for Immune Thrombocytopenia
23天前
FDA Grants Type B Pre-IND Meeting for RTX-NP (MabionCD20) in Immune Thrombocytopenia
去年
FDA Accepts Sobi's Avatrombopag (DOPTELET®) Application for Pediatric ITP Treatment
去年
TAVALISSE® (Fostamatinib) Approved in Mexico for Chronic ITP Treatment
去年
NIH Launches Study of Fostamatinib for Sickle Cell Disease Treatment
去年
First Generic Eltrombopag Launches, Expanding Access for Thrombocytopenia and Aplastic Anemia Patients
第 1 页，共 1224 页
上一页
下一页
